Stock listing
NASDAQ:BRVE Braveheart Bio, Inc. Stock
Home listing (NASDAQ) of Braveheart Bio, Inc.
Follow Braveheart Bio, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:BRVE
$18.78 USD -0.71 (-3.6%)
Close on Nov 17, 2026
- Day range
- $17.79 – $19.46 USDNov 17, 2026
- Volume
- 971,285 sharesNov 17, 2026
- Market cap
- $1.69B USDAt the close on Nov 17, 2026 · price × 90.04M shares outstanding
- Traded on an average day
- $10.37M USDMedian day 335,322 shares · last 3 months, Aug 17, 2026 – Nov 17, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BRVE · Home | $18.78 USD | -0.71 (-3.6%) | 971,285 | $19.46 | $19.46 | $17.79 | $19.49 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 17, 2026 · NASDAQ:BRVE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $18.78 | -0.71 | -3.6% | $19.46 | $19.46 | $17.79 | 971,285 | |
| $19.49 | -0.13 | -0.7% | $20.04 | $20.21 | $18.71 | 725,376 | |
| $19.62 | -0.88 | -4.3% | $20.41 | $20.41 | $19.19 | 536,604 | |
| $20.50 | -0.40 | -1.9% | $20.97 | $21.30 | $20.01 | 256,070 | |
| $20.90 | +1.28 | +6.5% | $20.04 | $21.85 | $19.41 | 488,966 | |
| $19.62 | +0.16 | +0.8% | $19.13 | $19.76 | $18.88 | 211,466 | |
| $19.46 | +0.86 | +4.6% | $19.08 | $19.87 | $18.61 | 618,350 | |
| $18.60 | +1.185 | +6.8% | $17.55 | $18.99 | $16.89 | 702,051 | |
| $17.42 | -2.69 | -13.4% | $19.84 | $19.84 | $16.70 | 1,590,097 | |
| $20.11 | -1.285 | -6.0% | $21.54 | $21.56 | $19.16 | 655,535 | |
| $21.39 | +0.35 | +1.7% | $20.94 | $21.53 | $20.24 | 305,539 | |
| $21.04 | -0.47 | -2.2% | $21.79 | $21.79 | $20.51 | 260,119 | |
| $21.51 | +0.32 | +1.5% | $21.29 | $21.77 | $20.75 | 533,666 | |
| $21.19 | -0.57 | -2.6% | $21.55 | $22.20 | $20.62 | 304,125 | |
| $21.76 | -0.06 | -0.3% | $21.74 | $21.85 | $20.77 | 246,219 | |
| $21.82 | -0.05 | -0.2% | $22.00 | $22.22 | $21.38 | 156,109 | |
| $21.87 | +0.43 | +2.0% | $21.71 | $21.96 | $21.32 | 101,220 | |
| $21.44 | -0.04 | -0.2% | $21.45 | $21.53 | $20.58 | 119,555 | |
| $21.48 | +0.44 | +2.1% | $21.14 | $21.80 | $20.68 | 156,502 | |
| $21.04 | +0.77 | +3.8% | $20.64 | $21.36 | $19.67 | 224,146 | |
| $20.27 | +1.06 | +5.5% | $19.21 | $20.81 | $19.15 | 323,870 | |
| $19.21 | +0.50 | +2.7% | $18.72 | $19.42 | $18.15 | 333,743 | |
| $18.71 | -0.84 | -4.3% | $19.50 | $19.59 | $18.00 | 414,900 | |
| $19.55 | +0.21 | +1.1% | $19.54 | $20.13 | $19.18 | 206,100 | |
| $19.34 | +0.01 | +0.1% | $19.33 | $19.90 | $18.62 | 462,800 | |
| $19.33 | -1.03 | -5.1% | $20.44 | $20.56 | $19.04 | 212,300 | |
| $20.36 | +0.34 | +1.7% | $20.17 | $20.78 | $19.22 | 155,100 | |
| $20.02 | +0.93 | +4.9% | $18.91 | $20.24 | $18.44 | 255,000 | |
| $19.09 | +0.51 | +2.7% | $18.53 | $19.32 | $17.86 | 389,200 | |
| $18.58 | -1.21 | -6.1% | $19.61 | $19.65 | $18.47 | 336,900 | |
| $19.79 | -1.56 | -7.3% | $21.59 | $21.59 | $19.67 | 590,300 | |
| $21.35 | +0.08 | +0.4% | $21.57 | $22.02 | $19.83 | 889,000 | |
| $21.27 | -0.14 | -0.7% | $21.44 | $21.98 | $20.77 | 462,800 | |
| $21.41 | +1.21 | +6.0% | $19.90 | $22.36 | $19.88 | 669,400 | |
| $20.20 | -2.14 | -9.6% | $22.30 | $22.30 | $20.01 | 967,500 | |
| $22.34 | +1.27 | +6.0% | $21.00 | $22.51 | $20.37 | 719,200 | |
| $21.07 | +0.45 | +2.2% | $20.25 | $22.05 | $20.01 | 389,300 | |
| $20.62 | -2.75 | -11.8% | $23.58 | $23.86 | $20.53 | 471,800 | |
| $23.37 | +1.91 | +8.9% | $21.41 | $23.80 | $20.70 | 396,700 | |
| $21.46 | -2.15 | -9.1% | $23.21 | $23.77 | $21.31 | 521,700 | |
| $23.61 | -1.41 | -5.6% | $25.41 | $25.41 | $23.42 | 829,400 | |
| $25.02 | -4.18 | -14.3% | $28.90 | $28.90 | $24.63 | 1,570,800 | |
| $29.20 | +1.49 | +5.4% | $27.78 | $29.50 | $27.47 | 2,017,800 | |
| $27.71 | +0.26 | +0.9% | $27.76 | $28.90 | $27.16 | 577,400 | |
| $27.45 | +0.74 | +2.8% | $26.82 | $28.90 | $26.22 | 550,700 | |
| $26.71 | -0.31 | -1.1% | $26.95 | $27.98 | $26.31 | 275,000 | |
| $27.02 | +0.38 | +1.4% | $26.75 | $27.76 | $26.29 | 209,200 | |
| $26.64 | -0.61 | -2.2% | $28.12 | $28.74 | $26.54 | 283,600 | |
| $27.25 | -1.66 | -5.7% | $28.94 | $29.50 | $26.47 | 286,000 | |
| $28.91 | -0.50 | -1.7% | $29.13 | $29.97 | $27.93 | 309,700 | |
| $29.41 | +2.67 | +10.0% | $27.18 | $29.91 | $27.18 | 613,200 | |
| $26.74 | +0.47 | +1.8% | $25.81 | $27.48 | $25.39 | 272,100 | |
| $26.27 | -0.68 | -2.5% | $27.22 | $27.22 | $25.19 | 327,600 | |
| $26.95 | +0.67 | +2.5% | $26.53 | $27.78 | $25.69 | 394,500 | |
| $26.28 | +0.78 | +3.1% | $25.76 | $27.06 | $24.90 | 342,900 | |
| $25.50 | -1.94 | -7.1% | $27.95 | $27.95 | $24.31 | 806,200 | |
| $27.44 | -0.42 | -1.5% | $27.98 | $29.24 | $27.38 | 162,500 | |
| $27.86 | +0.10 | +0.4% | $27.50 | $29.00 | $27.50 | 127,800 | |
| $27.76 | +0.12 | +0.4% | $27.80 | $28.65 | $27.01 | 215,200 | |
| $27.64 | +0.14 | +0.5% | $28.29 | $29.25 | $27.07 | 155,335 | |
| $27.50 | -0.08 | -0.3% | $27.64 | $28.00 | $26.17 | 101,993 | |
| $27.58 | +0.16 | +0.6% | $27.49 | $28.10 | $27.12 | 130,500 | |
| $27.42 | -1.55 | -5.4% | $28.43 | $28.89 | $26.54 | 176,200 | |
| $28.97 | +2.22 | +8.3% | $26.99 | $30.12 | $26.86 | 391,800 | |
| $26.75 | -0.91 | -3.3% | $27.64 | $28.50 | $25.76 | 215,000 | |
| $27.66 | +0.63 | +2.3% | $26.97 | $28.29 | $26.67 | 310,200 |
- Ticker
- NASDAQ:BRVE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 10, 2026
Braveheart Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
Latest deck · May 11, 2026
Technical Presentation (May 2026)
Technical · 16 slides
Latest news
Braveheart Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 10, 2026
Closed $20.90 (+6.5%) on Nov 11, 2026
Braveheart Bio to Participate in the Jefferies Global Healthcare Conference in London
Nov 9, 2026
Closed $19.46 (+4.6%) on Nov 9, 2026
Hengrui Pharma and Braveheart Bio Present Data from 52-Week Open-Label Extension of Phase 2 Study of HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy at American Heart Association Scientific Sessions 2026
Nov 6, 2026
Closed $18.60 (+6.8%) on Nov 6, 2026
Braveheart Bio to Host Webinar – HCM Spotlight: Advancing a Next-Generation Cardiac Myosin Inhibitor – with Key Opinion Leader Discussion on November 6, 2026
Oct 30, 2026
Closed $21.51 (+1.5%) on Oct 30, 2026
Braveheart Bio Announces Upcoming Presentations at the American Heart Association Scientific Sessions 2026
Oct 30, 2026
Closed $21.51 (+1.5%) on Oct 30, 2026
Braveheart Bio to Participate in Stifel Cardiometabolic Forum
Sep 16, 2026
Closed $27.71 (+0.9%) on Sep 17, 2026
Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
Sep 8, 2026
Closed $28.91 (-1.7%) on Sep 9, 2026
Braveheart Bio to Participate in Cantor Global Healthcare Conference
Sep 1, 2026
Closed $26.95 (+2.5%) on Sep 2, 2026
Financings
Public offering of common stock
Sep 8, 2026
Closed: US$439.9M in the latest tranche · US$18 a share · Goldman Sachs & Co. LLC +4
Dealers: Goldman Sachs & Co. LLC (co-lead), Jefferies (co-lead), TD Cowen (co-lead), Stifel (co-lead), Cantor (co-lead)
Announced Aug 6, 2026 · Closed Aug 7, 2026 · Closed Sep 8, 2026
Decks
Technical Presentation (May 2026)
Technical · 16 slides · May 11, 2026
Technical Presentation
Technical · 15 slides
Braveheart Bio, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 10 in the last 12 months · 10 in all · newest Nov 10, 2026 · oldest 2026
- Decks
- 2 decks · latest May 11, 2026
Where Braveheart Bio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BRVE · Home listing · This page | NASDAQ | United States | USD |
| BOATS:BRVE | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Braveheart Bio, Inc.